Litigation

Wilson Sonsini Goodrich & Rosati Expands IP Litigation Practice

PALO ALTO, Calif. - Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, is pleased to announce that Jeffrey Alan Hovden has become a partner at the firm. An experienced intellectual property litigator and counselor with particular expertise in pharmaceuticals, Hovden formerly was a partner at Katten Muchin Rosenman. He will be based in the firm's New York office.

Hovden specializes in patent litigation with a focus on pharmaceutical cases under the Hatch-Waxman Act and within the biotechnology industry more broadly. He has litigated numerous patent infringement and invalidity actions, including many cases involving top-selling, global prescription drugs for both generic and name-brand pharmaceutical companies. In addition to his robust litigation practice, Hovden advises clients on their intellectual property portfolios. He has extensive experience with the Food, Drug and Cosmetic Act's drug-approval provisions and their attendant regulations, and provides infringement, validity and due diligence opinions. In addition, Hovden has experience with copyrights, particularly ones involving functional works, and counsels his biotechnology clients regarding licensing matters.

Before his tenure at Katten, Hovden was a partner at Frommer Lawrence & Haug. Conversant in Japanese, he received his J.D. from the Columbia University School of Law in 1993 and a B.A., summa cum laude, with majors in biology and philosophy from the University of Minnesota in 1988.

Celebrating its 50th anniversary in 2011, Wilson Sonsini Goodrich & Rosati offers a broad range of services and legal disciplines focused on serving the principal challenges faced by the management and boards of directors of business enterprises. With long-standing roots in Silicon Valley, Wilson Sonsini Goodrich & Rosati has offices in Austin, Hong Kong, New York, Palo Alto, San Diego, San Francisco, Seattle, Shanghai and Washington, D.C. For more information, visit www.wsgr.com.